Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
featured
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices

  • 8 views
  • 08 Nov, 2020
  • 1 location
Treatment for Classical Hodgkin Lymphoma in Children and Adolescents

Reduction of the indication for radiotherapy (RT) in newly diagnosed patients with classical Hodgkins lymphoma without compromising cure rates. Investigation of a chemotherapy intensification randomisation in intermediate and advanced classical Hodgkins lymphoma patients to compensate for reduction in RT.

  • 3 views
  • 08 Nov, 2020
  • 1 location
Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

The primary objective of the study is to evaluate the efficacy of tislelizumab in participants with relapsed/refractory classical Hodgkin lymphoma, as measured by the overall response rate per

lymphoma
cancer
measurable disease
brentuximab
refractory classical hodgkin lymphoma
  • 0 views
  • 13 Dec, 2020
  • 19 locations
Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents

lymphoma without compromising cure rates and to investigate a chemotherapy intensification randomisation in intermediate and advanced classical Hodgkin lymphoma to compensate for reduction in radiotherapy

lymphoma
prednisone
vincristine
cyclophosphamide
dacarbazine
  • 62 views
  • 16 Apr, 2020
  • 20 locations
HD21 for Advanced Stages

Primary objective of the trial is to demonstrate non-inferior efficacy of six cycles of BrECADD compared to six cycles of escalated BEACOPP, each followed by radiotherapy to PET-positive residual lesions 2.5 cm, in terms of progression free survival (efficacy objective). If non-inferior efficacy can be shown, the co-primary objective is …

lymphoma
bleomycin
prednisone
brentuximab
doxorubicin
  • 0 views
  • 10 Nov, 2019
  • 1 location
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment

The purpose of this study is to compare ofatumumab & chlorambucil (O-Chl) versus ofatumumab & bendamustine (O-B) in patients with Chronic Lymphocytic Leukaemia who are considered not fit

anemia
thrombocytopenia
rituximab
chronic lymphocytic leukemia
lymphocytosis
  • 436 views
  • 08 Nov, 2020
  • 1 location
Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma

The purpose of this study is to determine if the XPO1 E571K mutation could be used as molecular residual disease biomarker in classical Hodgkin's lymphoma. To determine the interest of the

lymphoma
adriamycin
prednisone
vinblastine
xpo1
  • 0 views
  • 08 Nov, 2020
  • 1 location
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)

approaches (earle favorable, early unfavorable and advanced stages) to first line chemotherapy for classical Hodgkin Lymphoma (HL).

  • 0 views
  • 02 Dec, 2020
  • 1 location
Doxorubicin Hydrochloride Pembrolizumab Vinblastine and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

This phase II trial studies the side effects of doxorubicin hydrochloride, pembrolizumab, vinblastine, and dacarbazine in treating patients with classical Hodgkin lymphoma. Drugs used in

lymphoma
adriamycin
bleomycin
vinblastine
pembrolizumab
  • 0 views
  • 28 Sep, 2020
  • 1 location
Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

This is a prospective phase II clinical trial to observe the efficacy and safety of Camrelizumab combined with AVD in the first-line treatment for patients with advanced classical Hodgkin's

lymphoma
vincristine
camrelizumab
dacarbazine
epirubicin
  • 0 views
  • 09 Jan, 2021
  • 1 location